Central monitoring can reveal patterns that are difficult to see one site at a time. Unusual visit timing, missing assessments, or inconsistent measurements can prompt investigation. A signal, however, is not itself a finding of error or misconduct.
The FDA’s final risk-based monitoring Q&A is a useful reference. This article proposes an approach to reviewing signals so they lead to proportionate, evidence-based action.
1. Define the signal’s purpose
Identify the risk a metric is intended to detect and the data it requires. Explain the denominator, observation window, and comparison group. A site with few participants may appear extreme because of small numbers rather than a systematic problem.
For a hypothetical missed-visit indicator, distinguish visits that are not yet due from those that are overdue. Adjust the operational definition before interpreting a high rate. Otherwise, the metric may reflect transfer timing or scheduling conventions rather than collection performance.
2. Examine competing explanations
A cluster of unusual values could arise from equipment, unit conversion, population characteristics, or a data-processing issue. Review source context and transfer specifications before deciding what action is appropriate. Statistical unusualness should guide investigation, not replace it.
Keep the signal record connected to the affected observations and the data snapshot. A later refresh may resolve an apparent issue, but the review history should still explain why the original signal was raised and how it was assessed.
3. Use proportionate escalation
Define who investigates, who decides, and what evidence closes the issue. Some signals need a data query; others may require site support, a vendor correction, or clinical review. Avoid using one escalation pathway for every kind of pattern.
ICH E6(R3) provides the oversight context. Our practical recommendation is to separate the automated detection step from the qualified interpretation and resolution steps, with responsibility explicit at each boundary.
4. Learn from resolved signals
Record false positives, confirmed issues, and recurring causes. Review whether a threshold remains useful and whether the underlying process should change. A metric that repeatedly produces noise can consume attention needed for more consequential risks.
ICH E8(R1) is useful additional reading for prioritizing critical study factors. A monitoring dashboard should make those priorities easier to act on, not present every metric with identical visual weight.
The most useful central monitoring system supports a complete review loop: detect, contextualize, investigate, resolve, and learn. Its value comes from better oversight decisions and documented evidence, rather than the volume of alerts it generates.
